Singh – Systemic biomarkers in electronic cigarette users – 00182-2019 ERJ Open Res 2019

Systemic biomarkers in electronic cigarette users: implications for noninvasive assessment of vaping associated pulmonary injuries

Kameshwar P. Singh, Gina Lawyer, Thivanka Muthumalage, Krishna P. Maremanda, Naushad Ahmad Khan, Samantha R. McDonough, Dongxia Ye, Scott McIntosh and Irfan Rahman

Anthony Brown2021-04-23T19:26:58+00:00

Related Posts

Felicione – Comparing Pod and Mod ENDS Users: User and Product Characteristics, Use Patterns, and Biomarkers of Exposure and Harm

Felicione – Comparing Pod and Mod ENDS Users: User and Product Characteristics, Use Patterns, and Biomarkers of Exposure and Harm

Smith – Are E-Cigarette Flavors Associated with Exposure to Nicotine and Toxicants? Findings from Wave 2 of the Population Assessment of Tobacco and Health (PATH) Study

Smith – Are E-Cigarette Flavors Associated with Exposure to Nicotine and Toxicants? Findings from Wave 2 of the Population Assessment of Tobacco and Health (PATH) Study

White – Tobacco Product Access Scenarios Influence Hypothetical Use Behaviors

White – Tobacco Product Access Scenarios Influence Hypothetical Use Behaviors

Gao – Electronic Cigarette Users’ Perspective on the COVID-19 Pandemic- JMIR Public Health Surveill 2021

Gao – Electronic Cigarette Users’ Perspective on the COVID-19 Pandemic- JMIR Public Health Surveill 2021

Shi – Association of flavored electronic nicotine delivery system (ENDS) use with self-reported chronic obstructive pulmonary disease (COPD): results from the PATH study, Wave 4

Shi – Association of flavored electronic nicotine delivery system (ENDS) use with self-reported chronic obstructive pulmonary disease (COPD): results from the PATH study, Wave 4